Follow
Matthijs Kruizinga
Matthijs Kruizinga
Juliana Children's Hospital
Verified email at hagaziekenhuis.nl
Title
Cited by
Cited by
Year
The impact of lockdown on pediatric ED visits and hospital admissions during the COVID19 pandemic: a multicenter analysis and review of the literature
MD Kruizinga, D Peeters, M van Veen, M van Houten, J Wieringa, ...
European journal of pediatrics 180, 2271-2279, 2021
1542021
Risk factors, treatment, and immune dysregulation in autoimmune cytopenia after allogeneic hematopoietic stem cell transplantation in pediatric patients
MD Kruizinga, MJD van Tol, V Bekker, T Netelenbos, FJ Smiers, ...
Biology of Blood and Marrow Transplantation 24 (4), 772-778, 2018
602018
Development of novel, value-based, digital endpoints for clinical trials: a structured approach toward fit-for-purpose validation
MD Kruizinga, FE Stuurman, V Exadaktylos, RJ Doll, DT Stephenson, ...
Pharmacological Reviews 72 (4), 899-909, 2020
352020
Technical validity and usability of a novel smartphone‐connected spirometry device for pediatric patients with asthma and cystic fibrosis
MD Kruizinga, E Essers, FE Stuurman, A Zhuparris, N van Eik, ...
Pediatric Pulmonology 55 (9), 2463-2470, 2020
192020
The future of clinical trial design: the transition from hard endpoints to value-based endpoints
MD Kruizinga, FE Stuurman, GJ Groeneveld, AF Cohen
Concepts and Principles of Pharmacology: 100 Years of the Handbook of …, 2019
172019
Pharmacokinetics of intravenous and inhaled salbutamol and tobramycin: An exploratory study to investigate the potential of exhaled breath condensate as a matrix for …
MD Kruizinga, WAJ Birkhoff, MJ van Esdonk, NB Klarenbeek, ...
British Journal of Clinical Pharmacology 86 (1), 175-181, 2020
142020
Finding suitable clinical endpoints for a potential treatment of a rare genetic disease: the case of ARID1B
MD Kruizinga, RGJA Zuiker, E Sali, ML de Kam, RJ Doll, GJ Groeneveld, ...
Neurotherapeutics 17, 1300-1310, 2020
112020
Towards remote monitoring in pediatric care and clinical trials—Tolerability, repeatability and reference values of candidate digital endpoints derived from physical activity …
MD Kruizinga, N Heide, A Moll, A Zhuparris, Y Yavuz, ML Kam, ...
PloS one 16 (1), e0244877, 2021
102021
The use of intravenous pentamidine for the prophylaxis of Pneumocystis pneumonia in pediatric patients
MD Kruizinga, D Bresters, FJ Smiers, AC Lankester, RGM Bredius
Pediatric Blood & Cancer 64 (8), e26453, 2017
92017
Effect of intellivent-asv versus conventional ventilation on ventilation intensity in patients with covid-19 ards—an observational study
LA Buiteman-Kruizinga, HE Mkadmi, A Serpa Neto, MD Kruizinga, ...
Journal of Clinical Medicine 10 (22), 5409, 2021
82021
Development and technical validation of a smartphone-based cry detection algorithm
A ZhuParris, MD Kruizinga, M Gent, E Dessing, V Exadaktylos, RJ Doll, ...
Frontiers in pediatrics 9, 651356, 2021
72021
Adverse effect of lockdowns during the COVID-19 pandemic: increased incidence of pediatric crisis admissions due to eating disorders and adolescent intoxications
JM Kersten, M van Veen, MA van Houten, J Wieringa, JG Noordzij, ...
European Journal of Pediatrics 182 (3), 1137-1142, 2023
62023
Saliva as a sampling matrix for therapeutic drug monitoring of gentamicin in neonates: A prospective population pharmacokinetic and simulation study
A Samb, M Kruizinga, Y Tallahi, M van Esdonk, W van Heel, G Driessen, ...
British Journal of Clinical Pharmacology 88 (4), 1845-1855, 2022
52022
Development and technical validation of a smartphone‐based pediatric cough detection algorithm
MD Kruizinga, A Zhuparris, E Dessing, FJ Krol, AJ Sprij, RJ Doll, ...
Pediatric Pulmonology 57 (3), 761-767, 2022
52022
Postdischarge recovery after acute pediatric lung disease can be quantified with digital biomarkers
MD Kruizinga, A Moll, A Zhuparris, D Ziagkos, FE Stuurman, M Nuijsink, ...
Respiration 100 (10), 979-988, 2021
52021
Effect of lockdowns on the epidemiology of pediatric respiratory disease—A retrospective analysis of the 2021 summer epidemic
MD Kruizinga, JG Noordzij, MA van Houten, J Wieringa, ...
Pediatric Pulmonology 58 (4), 1229-1236, 2023
42023
Theoretical performance of nonlinear mixed-effect models incorporating saliva as an alternative sampling matrix for therapeutic drug monitoring in pediatrics: a simulation study
MD Kruizinga, FE Stuurman, GJA Driessen, AF Cohen, KR Bergmann, ...
Therapeutic Drug Monitoring 43 (4), 546-554, 2021
42021
Clinical validation of digital biomarkers for paediatric patients with asthma and cystic fibrosis: potential for clinical trials and clinical care
MD Kruizinga, E Essers, FE Stuurman, Y Yavuz, ML de Kam, A Zhuparris, ...
European Respiratory Journal 59 (6), 2022
32022
Mitochondrial function, grip strength, and activity are related to recovery of mobility after a total knee arthroplasty
MPJ van Diemen, D Ziagkos, MD Kruizinga, MR Bénard, P Lambrechtse, ...
Clinical and Translational Science 16 (2), 224-235, 2023
22023
Objective home-monitoring of physical activity, cardiovascular parameters, and sleep in pediatric obesity
JM Knijff, ECAM Houdijk, D van der Kaay, Y van Berkel, L Filippini, ...
Digital biomarkers 6 (1), 19-30, 2022
22022
The system can't perform the operation now. Try again later.
Articles 1–20